Therefore, inhibition of FTase by low‐dose tipifarnib exhibits an antitumor effect by decreasing HIF‐1α expression in MKN45 and KATOIII cells, which are HIF‐1α‐positive GC cell lines. Here, HIF1A is linked to gastric cancer.